Cysteine is a better predictor of coronary artery disease than conventional homocysteine in high-risk subjects under preventive medication

被引:7
|
作者
Lima, Ana [1 ]
Ferin, Rita [1 ]
Fontes, Antonio [2 ]
Santos, Emilia [2 ]
Martins, Dinis [2 ]
Baptista, Jose [1 ]
Pavao, Maria L. [1 ]
机构
[1] Univ Azores, DCFQE Fac Sci & Technol, P-9501855 Ponta Delgada, Azores, Portugal
[2] Hosp Divino Espirito Santo Ponta Delgada EPER, Cardiol Dept, Ave D Manuel, P-9500782 Ponta Delgada, Azores, Portugal
关键词
Coronary artery disease; Plasma and erythrocyte aminothiols; Hypercysteinemia; Hyperhomocy-steinemia; GAMMA-GLUTAMYL-TRANSFERASE; PLASMA TOTAL CYSTEINE; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; N-ACETYLCYSTEINE; HEART; CHOLESTEROL; GLUTATHIONE; BIOMARKERS; THIOL;
D O I
10.1016/j.numecd.2020.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: In Portugal, The Azores Archipelago has the highest standardized mortality rate for CAD. Therefore, the aim of this study was to evaluate conventional risk factors, as well as plasma and erythrocyte aminothiol concentration in high-risk Azorean patients undergoing elective coronary angiography and to investigate whether any aminothiol was associated with CAD risk and severity. Methods and results: 174 subjects with symptomatic CAD (age 569y; 68% men) submitted to coronary angiography were split into 2 groups: one formed by CAD patients ( 50% stenosis in at least one major coronary vessel) and the other by non-CAD patients (<50% stenosis). Both groups were age-, sexand BMI-matched. Plasma and erythrocyte aminothiol profiles were evaluated by RP-HPLC/FLD. CAD patients significantly exhibited both higher concentrations of plasma Cys and hypercysteinemia (Cys > 300 mu M) prevalence than those in the non-CAD group (261 58 mu M vs. 243 +/- 56 mu M; 22% vs. 10%, respectively). No differences were observed between groups regarding plasma Hcy levels or hyperhomocysteinemia prevalence. After adjustment for several confounders (including Hcy), subjects in the highest quartile of plasma Cys had a 3.31 (95% CI, 1.32-8.30, p = 0.011) fold risk for CAD, compared with those in the lowest quartiles. Furthermore, plasma Cys levels (but not Hcy) tended to increase with the number of stenotic vessels (1VD: 253 +/- 64 mu M; 2VD: 262 +/- 52 mu M; 3VD: 279 +/- 57 mu M, p = 0.129). Conclusion: Hypercysteinemia revealed to be a better predictor of CAD than hyperhomocysteinemia. Moreover, plasma Cys showed to be a useful biomarker for CAD both in primary and secondary preventions, seeming to resist better than Hcy to oral medication therapy. (C) 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1281 / 1288
页数:8
相关论文
共 50 条
  • [1] Awareness of coronary artery disease risk factors and homocysteine treatment in high-risk patients
    Salo, D
    Lavery, RF
    Olesnicky, N
    Milano, M
    ANNALS OF EMERGENCY MEDICINE, 2003, 42 (04) : S37 - S38
  • [2] Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects
    Yunjun Xiao
    Yuan Zhang
    Xiaofei Lv
    Dongfang Su
    Dan Li
    Min Xia
    Jian Qiu
    Wenhua Ling
    Jing Ma
    Lipids in Health and Disease, 10
  • [3] Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects
    Xiao, Yunjun
    Zhang, Yuan
    Lv, Xiaofei
    Su, Dongfang
    Li, Dan
    Xia, Min
    Qiu, Jian
    Ling, Wenhua
    Ma, Jing
    LIPIDS IN HEALTH AND DISEASE, 2011, 10
  • [4] Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors
    Hirashiki, A
    Yamada, Y
    Murase, Y
    Suzuki, Y
    Kataoka, H
    Morimoto, Y
    Tajika, T
    Murohara, T
    Yokota, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (08) : 1429 - 1437
  • [5] IS THERE A BETTER LIPOPROTEIN PREDICTOR OF CORONARY-ARTERY DISEASE THAN HIGH-DENSITY LIPOPROTEIN
    SCHMIDT, S
    WASSERMAN, AG
    ROSS, AM
    SCHLESSELMAN, S
    MUESING, R
    LAROSA, JC
    CIRCULATION, 1983, 68 (04) : 159 - 159
  • [6] Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors - Reply
    Hirashiki, A
    Yamada, Y
    Yokota, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) : 209 - 210
  • [7] Lipoprotein(a) and Homocysteine Potentiate the Risk of Coronary Artery Disease in Male Subjects
    Alfonso Banos-Gonzalez, Manuel
    Angles-Cano, Eduardo
    Cardoso-Saldana, Guillermo
    Antonio Pena-Duque, Marco
    Antonio Martinez-Rios, Marco
    Valente-Acosta, Benjamin
    Gonzalez-Pacheco, Hector
    de la Pena-Diaz, Aurora
    CIRCULATION JOURNAL, 2012, 76 (08) : 1953 - 1957
  • [8] Coronary Calcium Score as a Predictor for Coronary Artery Disease and Cardiac Events in Japanese High-Risk Patients
    Yamamoto, Hideya
    Ohashi, Norihiko
    Ishibashi, Ken
    Utsunomiya, Hiroto
    Kunita, Eiji
    Oka, Toshiharu
    Horiguchi, Jun
    Kihara, Yasuki
    CIRCULATION JOURNAL, 2011, 75 (10) : 2424 - 2431
  • [9] The Correlation of MTHFR SNPs, Homocysteine, and Conventional Risk Predictors with Coronary Artery Disease
    R. Masud
    A. U. H. Khan
    H. Z. Baqai
    A. Iqbal
    Russian Journal of Genetics, 2021, 57 : 1328 - 1336
  • [10] The Correlation of MTHFR SNPs, Homocysteine, and Conventional Risk Predictors with Coronary Artery Disease
    Masud, R.
    Khan, A. U. H.
    Baqai, H. Z.
    Iqbal, A.
    RUSSIAN JOURNAL OF GENETICS, 2021, 57 (11) : 1328 - 1336